Acquisitions and Divestitures (Tables)

6 Months Ended

Jun. 30, 2012

Acquisitions and Divestitures

Schedule of fair value of consideration transferred

	Fair Value at the Acquisition Date
	(Provisional)
Cash	$	363,405
Contingent consideration	169,337
Total fair value of consideration transferred	$	532,742

Schedule of purchase price allocated to assets acquired and liabilities assumed at acquisition date

	Amounts Recognized as of Acquisition Date (Provisional)
Working capital (1)	$	11,987
Property, plant and equipment	2,559
Platform technology intangible asset (2)	330,800
In-process research and development product rights	198,400
Net deferred tax liability (3)	(164,993)
Total identifiable net assets	378,753
Goodwill	153,989
Net assets acquired	$	532,742

(1)Includes cash and cash equivalents, accounts receivable, other current assets, accounts payable and other current liabilities.

(2)Platform technology related to the Avilomics™ discovery platform which is being amortized over a useful life of seven years based on the estimated useful life of the underlying process.

(3)Includes current deferred income tax asset of $14.7 million and non-current deferred tax liability of $179.7 million.